Response to: RSBMT-2018-0270.R2 - Pain and quality of life in human T cell lymphotropic virus type 1 associated myelopathy or tropical spastic paraparesis after home-based exercise protocol: Randomized clinical trial

We would like to thank the reviewers for their comments regarding the possibility of the noninclusion of patients with psychiatric and neurological comorbidities in our study. This would have been very interesting, but it would be almost impossible to conduct such an investigation. Regarding the noninclusion of patients with neurological conditions, this would not apply to a sample with associated myelopathy (HAM/TSP), as this is a neurological condition per se. The noninclusion of patients with comorbid psychiatric symptoms would have helped answer the question of the efficacy of an exercise protocol in the control of pain, but around 70% of our symptomatic patients with HAM/TSP present depression traits as comorbidity¹. Hence, their exclusion would substantially decrease the sample size and prevent the study from being developed. Furthermore, and probably based on the same difficulties, many studies investigating disability^2,3,4, and exercises^5,6,7 in HTLV-1 patients with or without HAM/TSP did not use the presence of psychiatric disorders as noninclusion criteria. Based on these facts, the proposed procedure for non-including patients with psychiatric disorders in HTLV-1 studies of pain seems to be unfeasible. Even controlling the results for the presence of these symptoms tends to be difficult, as this analytic approach would fall into low statistical power due to unbalanced groups.

REFERENCES

• ¹
  Gascón MRP, Capitão CG, Casseb J, Nogueira-Martins MCF, Smid J, Oliveira ACP de. Prevalence of anxiety, depression and quality of life in HTLV-1 infected patients. Braz J Infect Dis. 2011;15(6):578-82.
• ²
  Franzoi AC, Araújo AQC. Disability profile of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis using the Functional Independence Measure (FIM). Spinal Cord. 2005;43(4):236-40.
• ³
  Franzoi AC, Araújo AQC. Disability and determinants of gait performance in tropical spastic paraparesis/HTLV-I associated myelopathy (HAM/TSP). Spinal Cord . 2007;45(1):64-8.
• ⁴
  Charlip E, Liu W, Massoud R, Billioux J, Caruso B, Ohayon J, et al. Patterns of spinal cord atrophy in HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP). Retrovirology. 2015:12(Suppl 1):P32.
• ⁵
  Borges J, Baptista AF, Santana N, Souza I, Kruschewsky RA, Galvão-Castro B, et al. Pilates exercises improve low back pain and quality of life in patients with HTLV-1 virus: a randomized crossover clinical trial. J Bodyw Mov Ther. 2014;18(1):68-74.
• ⁶
  Mota R de S, Macêdo MC, Corradini S, Patrício NA, Baptista AF, Sá KN. The effect of home exercise on the posture and mobility of people with HAM/TSP: a randomized clinical trial. Arq Neuropsiquiatr. 2020;78(3):149-57.
• ⁷
  Facchinetti LD, Araújo AQ, Silva MT, Leite ACC, Azevedo MF, Chequer GL, et al. Home-based exercise program in TSP/HAM individuals: a feasibility and effectiveness study. Arq Neuropsiquiatr . 2017;75(4):221-7.

Publication Dates

• Publication in this collection
  06 June 2022
• Date of issue
  2022

History

• Received
  23 Dec 2021
• Accepted
  30 Dec 2021